Cellular uptake and biocompatibility of bismuth ferrite harmonic advanced nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 4, 2015, Pages 815-824

  Staedler, Davide ^a   Passemard, Solène ^a   Magouroux, Thibaud ^b   Rogov, Andrii ^b   Maguire, Ciaran Manus ^c   Mohamed, Bashir M ^c   Schwung, Sebastian ^d   Rytz, Daniel ^d   Jüstel, Thomas ^e   Hwu, Stéphanie ^b   Mugnier, Yannick ^f   Le Dantec, Ronan ^f   Volkov, Yuri ^c,g   Gerber Lemaire, Sandrine ^a   Prina Mello, Adriele ^c,g   Bonacina, Luigi ^b   Wolf, Jean Pierre ^b  

^a EPFL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d FEE GMBH   (Germany)

^e UNIVERSITY OF APPLIED SCIENCES   (Germany)

^f UNIVERSITÉ DE SAVOIE   (France)

^g TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Biocompatibility; Bismuth ferrite; Nanophotonic; Non linear imaging; PEGylation

Indexed keywords

BIOCOMPATIBILITY; BISMUTH; CELL CULTURE; FERRITE; MEDICAL APPLICATIONS; NANOPARTICLES; NANOPHOTONICS; POLYETHYLENE GLYCOLS;

ADVANCED DIAGNOSTICS; BIOMEDICAL APPLICATIONS; BISMUTH FERRITE NANOPARTICLES; BISMUTH FERRITES; DIAGNOSTIC APPLICATIONS; HUMAN ADENOCARCINOMA; NONLINEAR IMAGING; PEGYLATION;

NANOMAGNETICS;

BISMUTH DERIVATIVE; BISMUTH FERRITE NANOPARTICLE; FERRITE; MACROGOL; NANOPARTICLE; UNCLASSIFIED DRUG; BIOCOMPATIBLE COATED MATERIAL; BISMUTH; CONTRAST MEDIUM; FERRIC ION;

A549 CELL LINE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CYTOTOXICITY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; NCI H520 CELL LINE; SQUAMOUS CELL CARCINOMA CELL LINE; THP 1 CELL LINE; CHEMISTRY; MATERIALS TESTING; TUMOR CELL LINE;

BISMUTH; CELL LINE, TUMOR; COATED MATERIALS, BIOCOMPATIBLE; CONTRAST MEDIA; FERRIC COMPOUNDS; HUMANS; MATERIALS TESTING; NANOPARTICLES;

EID: 84955560543     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.12.018     Document Type: Article

References (47)

1. Bonacina L., Mugnier Y., Courvoisier F., Le Dantec R., Extermann J., Lambert Y., et al. Polar Fe(IO3)(3) nanocrystals as local probes for nonlinear microscopy. Appl Phys B Lasers Opt 2007, 87:399-403.
2. Bonacina L. Nonlinear nanomedecine: harmonic nanoparticles toward targeted diagnosis and therapy. Mol Pharm 2013, 10:783-792.
3. Extermann J., Bonacina L., Cuna E., Kasparian C., Mugnier Y., Feurer T., et al. Nanodoublers as deep imaging markers for multi-photon microscopy. Opt Express 2009, 17:15342-15349.
4. Magouroux T., Extermann J., Hoffmann P., Mugnier Y., Le Dantec R., Jaconi M.E., et al. High-speed tracking of murine cardiac stem cells by harmonic nanodoublers. Small 2012, 8:2752-2756.
5. Pantazis P., Maloney J., Wu D., Fraser S.E. Second harmonic generating (SHG) nanoprobes for in vivo imaging. Proc Natl Acad Sci U S A 2010, 107:14535-14540.
6. Staedler D., Magouroux T., Hadji R., Joulaud C., Extermann J., Schwung S., et al. Harmonic nanocrystals for biolabeling: a survey of optical properties and biocompatibility. ACS Nano 2012, 6:2542-2549.
7. Zielinski M., Oron D., Chauvat D., Zyss J. Second-harmonic generation from a single core/shell quantum dot. Small 2009, 5:2835-2840.
8. Chou L.Y., Ming K., Chan W.C. Strategies for the intracellular delivery of nanoparticles. Chem Soc Rev 2011, 40:233-245.
9. Kim T.H., El-Said W.A., An J.H., Choi J.W. ITO/gold nanoparticle/RGD peptide composites to enhance electrochemical signals and proliferation of human neural stem cells. Nanomedicine 2013, 9:336-344.
10. Auwerx J. The human leukemia-cell line, Thp-1 - a multifaceted model for the study of monocyte-macrophage differentiation. Experientia 1991, 47:22-31.
11. Herd H., Daum N., Jones A.T., Huwer H., Ghandehari H., Lehr C.M. Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano 2013, 7:1961-1973.
12. Staedler D., Magouroux T., Passemard S., Schwung S., Dubled M., Schneiter G.S., et al. Deep UV generation and direct DNA photo-interaction by harmonic nanoparticles in labelled samples. Nanoscale 2014, 6:2929-2936.
13. Mohamed B.M., Verma N.K., Prina-Mello A., Williams Y., Davies A.M., Bakos G., et al. Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnol 2011, 9(29):1-14.
14. Prina-Mello A., Crosbie-Staunton K., Salas G., Morales M.D., Volkov Y. Multiparametric toxicity evaluation of SPIONs by high content screening technique: identification of biocompatible multifunctional nanoparticles for nanomedicine. IEEE Trans Magn 2013, 49:377-382.
15. Hak S., Helgesen E., Hektoen H.H., Huuse E.M., Jarzyna P.A., Mulder W.J., et al. The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging. ACS Nano 2012, 6:5648-5658.
16. Passemard S., Staedler D., Ucnova L., Schneiter G.S., Kong P., Bonacina L., et al. Convenient synthesis of heterobifunctional poly(ethylene glycol) suitable for the functionalization of iron oxide nanoparticles for biomedical applications. Bioorg Med Chem Lett 2013, 23:5006-5010.
17. Hole P., Sillence K., Hannell C., Maguire C.M., Roesslein M., Suarez G., et al. Interlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA). J Nanopart Res 2013, 15:2101.
18. Mohamed B.M., Verma N.K., Davies A.M., McGowan A., Crosbie-Staunton K., Prina-Mello A., et al. Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo. Nanomedicine (Lond) 2012, 7:1181-1195.
19. Movia D., Prina-Mello A., Volkov Y., Giordani S. Determination of spiropyran cytotoxicity by high content screening and analysis for safe application in bionanosensing. Chem Res Toxicol 2010, 23:1459-1466.
20. Movia D., Prina-Mello A., Bazou D., Volkov Y., Giordani S. Screening the cytotoxicity of single-walled carbon nanotubes using novel 3D tissue-mimetic models. ACS Nano 2011, 5:9278-9290.
21. Gupta A.K., Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience 2004, 3:66-73.
22. Kohro T., Tanaka T., Murakami T., Wada Y., Aburatani H., Hamakubo T., et al. A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J Atheroscler Thromb 2004, 11:88-97.
23. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10644-10654.
24. Lankoff A., Sandberg W.J., Wegierek-Ciuk A., Lisowska H., Refsnes M., Sartowska B., et al. The effect of agglomeration state of silver and titanium dioxide nanoparticles on cellular response of HepG2, A549 and THP-1 cells. Toxicol Lett 2012, 208:197-213.
25. Lee Y., Yang I., Lee J.E., Hwang S., Lee J.W., Um S.S., et al. Enhanced photocurrent generation by Forster resonance energy transfer between phospholipid-assembled conjugated oligoelectrolytes and Nile red. J Phys Chem C 2013, 117:3298-3307.
26. Hansen G.H., Rasmussen K., Niels-Christiansen L.L., Danielsen E.M. Endocytic trafficking from the small intestinal brush border probed with FM dye. Am J Physiol Gastrointest Liver Physiol 2009, 297:G708-G715.
27. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980, 26:171-176.
28. Chithrani B.D., Chan W.C. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 2007, 7:1542-1550.
29. Jin H., Heller D.A., Sharma R., Strano M.S. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 2009, 3:149-158.
30. Marquis B.J., Love S.A., Braun K.L., Haynes C.L. Analytical methods to assess nanoparticle toxicity. Analyst 2009, 134:425-439.
31. Jeng H.A., Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health A Tox Hazard Subst Environ Eng 2006, 41:2699-2711.
32. Lofrumento D.D., La Piana G., Abbrescia D.I., Palmitessa V., La Pesa V., Marzulli D., et al. Valinomycin induced energy-dependent mitochondrial swelling, cytochrome c release, cytosolic NADH/cytochrome c oxidation and apoptosis. Apoptosis 2011, 16:1004-1013.
33. Monteith D.K., Theiss J.C., Haskins J.R., de la Iglesia F.A. Functional and subcellular organelle changes in isolated rat and human hepatocytes induced by tetrahydroaminoacridine. Arch Toxicol 1998, 72:147-156.
34. He Q., Zhang J., Shi J., Zhu Z., Zhang L., Bu W., et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010, 31:1085-1092.
35. Choi J., Reipa V., Hitchins V.M., Goering P.L., Malinauskas R.A. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci 2011, 123:133-143.
36. Zhao Y.N., Sun X.X., Zhang G.N., Trewyn B.G., Slowing I.I., Lin V.S.Y. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 2011, 5:1366-1375.
37. Schwung S., Rogov A., Clarke G., Joulaud C., Magouroux T., Staedler D., et al. Nonlinear optical and magnetic properties of BiFeO3 harmonic nanoparticles. J. Appl. Phys 2014, 116:114306. 10.1063/1.4895836.
38. Geissbuehler M., Bonacina L., Shcheslavskiy V., Bocchio N.L., Geissbuehler S., Leutenegger M., et al. Nonlinear correlation spectroscopy (NLCS). Nano Lett 2012, 12:1668-1672.
39. Lin M.M., Kim H.H., Kim H., Dobson J., Kim do K. Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy. Nanomedicine (Lond) 2010, 5:109-133.
40. Shah N.B., Vercellotti G.M., White J.G., Fegan A., Wagner C.R., Bischof J.C. Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties. Mol Pharm 2012, 9:2146-2155.
41. Gil P.R., Parak W.J. Composite nanoparticles take aim at cancer. ACS Nano 2008, 2:2200-2205.
42. Perry J.L., Reuter K.G., Kai M.P., Herlihy K.P., Jones S.W., Luft J.C., et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett 2012, 12:5304-5310.
43. Verma A., Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
44. Hanley C., Thurber A., Hanna C., Punnoose A., Zhang J., Wingett D.G. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett 2009, 4:1409-1420.
45. Lesniak A., Fenaroli F., Monopoli M.R., Aberg C., Dawson K.A., Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 2012, 6:5845-5857.
46. Sayes C.M., Reed K.L., Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 2007, 97:163-180.
47. Siglienti I., Bendszus M., Kleinschnitz C., Stoll G. Cytokine profile of iron-laden macrophages: implications for cellular magnetic resonance imaging. J Neuroimmunol 2006, 173:166-173.